Morton's neuroma is a common problem. Progress has been made in the understanding of this frequent problem since Morton's original description and treatment. Today, we accept a failure rate of 15% to 20%, even in the best of series. We must ask ourselves if this is good enough. What can we do to achieve an acceptable failure of 5% or less? How can we improve? Only through an honest analysis and discussion can we improve the care that we deliver.